Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?
Dinna N. Cruz(UNSW Sydney), Rex L. Mahnensmith(Yale University), Ali K. Abu‐Alfa(Yale University), Mark A. Perazella(Yale University)
Cited by 54
Related Papers
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
|Nature Reviews Nephrology|2017|1.5k
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
|New England Journal of Medicine|2004|1.1k
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
|European Heart Journal|2009|1.1k
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|724
The Outcome of Neutrophil Gelatinase-Associated Lipocalin-Positive Subclinical Acute Kidney Injury
|Journal of the American College of Cardiology|2011|685